Indications and uses
Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Rodan + Fields Redefine AM Cream
- Manufacturer
- Rodan and Fields
- Effective date
- 2022-10-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 31
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:50:08
Label at a glance#
ProductRodan and Fields Redefine AM SPF 30
Active ingredientOCTISALATE, AVOBENZONE, OCTOCRYLENE, HOMOSALATE
Label structure10 sections
Dosage and administration
Apply a dime-sized amount evenly over entire face every morning and 15 minutes before sun exposure, avoiding the eye area. Use a water resistant sunscreen if swimming or sweating Reapply at least every 2 hours. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and ...
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredients
Avobenzone 3%
Homosalate 2.5%
Octisalate 5%
Octocrylene 2.7%
Purpose
Sunscreen
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
WARNINGS SECTION
Warnings For external use onyl
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply a dime-sized amount evenly over entire face every morning and 15 minutes before sun exposure, avoiding the eye area.
- Use a water resistant sunscreen if swimming or sweating
- Reapply at least every 2 hours.
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including.
- Limit time in the sun, especially from 10 a.m. - 2 p.m.
- Wear long-sleeve shirts, pants, hats and sunglasses
- Children under 6 months: Ask a doctor.
Inactive ingredients
Water, Isododecane, Ethylhexyl Pamitate, Polymethylsilsesquioxane, Glycerin, Dimethicone, Cetyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Butylene Glycol, Caprylyl Glycol, Sucrose Stearate, Olea Europaea (Olive) Fruit Extract, Hydrogenated Polydecene, Polyurethane-40, Hydrolyzed Silk, Fragrance, Silica, Camellia Oleifera Leaf Extract, Polyacrylate-13, Polyisobutene, Polysorbate-20, Iron Oxides, Tetrapeptide-21, Resveratrol, Phenoxyethanol, Chlorphenesin, Dunaliella Salina Extract, Talc, PEG-12 Dimethicone, Humic Acids, Sodium Hyaluronate
Other Information
Protect this product from excessive heat and direct sun
OTC - QUESTIONS SECTION
QUESTIONS OR COMMENTS 1-888-995-5656
HOW SUPPLIED SECTION
Manufactured for Rodan and Fields, LLC
11 Maiden Lane, Suite 400
San Francisco, CA 94108
Made in USA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 14 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 14 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 14 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 14 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 14 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 14 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 14 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 14 | |
| 1,3-BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 14 | |
| BLACK OLIVE | INACTIVE INGREDIENT | 2M6QWV94OC | 14 | |
| BOMBYX MORI FIBER | INACTIVE INGREDIENT | 6LK42KUV6W | 14 | |
| CAMELLIA OLEIFERA LEAF | INACTIVE INGREDIENT | 5077EL0C60 | 14 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 14 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 14 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 14 | |
| DUNALIELLA SALINA | INACTIVE INGREDIENT | F4O1DKI9A6 | 14 | |
| ETHYLHEXYL PALMITATE | INACTIVE INGREDIENT | 2865993309 | 14 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 14 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 14 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 14 | |
| GLYCERYL STEARATE SE | INACTIVE INGREDIENT | FCZ5MH785I | 14 | |
| HYDROGENATED POLYDECENE (550 MW) | INACTIVE INGREDIENT | U333RI6EB7 | 14 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 14 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 14 | |
| PEG-12 DIMETHICONE (300 CST) | INACTIVE INGREDIENT | ZEL54N6W95 | 14 | |
| PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER | INACTIVE INGREDIENT | 788QAG3W8A | 14 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 14 | |
| POLYISOBUTYLENE (1000 MW) | INACTIVE INGREDIENT | 5XB3A63Y52 | 14 | |
| POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) | INACTIVE INGREDIENT | 59Z907ZB69 | 14 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 14 | |
| RESVERATROL | INACTIVE INGREDIENT | Q369O8926L | 14 | |
| SILICA DIMETHYL SILYLATE | INACTIVE INGREDIENT | EU2PSP0G0W | 14 | |
| SODIUM POLYACRYLATE (8000 MW) | INACTIVE INGREDIENT | 285CYO341L | 14 | |
| SUCROSE STEARATE | INACTIVE INGREDIENT | 274KW0O50M | 14 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 14 | |
| TETRAPEPTIDE-21 | INACTIVE INGREDIENT | 179JUC43HU | 14 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 14 |
Products#
Every source-derived product name is available through these pages.
- Rodan and Fields Redefine AM SPF 30
- Octisalate, Avobenzone, Octocrylene, Homosalate
- PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER
- CAPRYLYL GLYCOL
- RESVERATROL
- SODIUM POLYACRYLATE (8000 MW)
- POLYISOBUTYLENE (1000 MW)
- POLYSORBATE 20
- OCTISALATE
- AVOBENZONE
- OCTOCRYLENE
- HOMOSALATE
- WATER
- ETHYLHEXYL PALMITATE
- PEG-100 STEARATE
- GLYCERYL STEARATE SE
- CETYL ALCOHOL
- ISODODECANE
- DIMETHICONE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- SILICA DIMETHYL SILYLATE
- FERRIC OXIDE RED
- TALC
- FERRIC OXIDE YELLOW
- PEG-12 DIMETHICONE (300 CST)
- CAMELLIA OLEIFERA LEAF
- PHENOXYETHANOL
- HYDROGENATED POLYDECENE (550 MW)
- DUNALIELLA SALINA
- BUTYLENE GLYCOL
- TETRAPEPTIDE-21
- BOMBYX MORI FIBER
- BLACK OLIVE
- SUCROSE STEARATE
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 14222-2250 | 14222-2250-1, 14222-2250-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | LOTION / TOPICAL | 2000 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SHAMPOO / TOPICAL | 8 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| SUCROSE STEARATE | SUCROSE STEARATE | 274KW0O50M | CAPSULE, EXTENDED RELEASE / ORAL | 57 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SILICA DIMETHYL SILYLATE | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | TABLET / SUBLINGUAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| SILICA DIMETHYL SILYLATE | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | CREAM / VAGINAL | 50 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / BUCCAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, DELAYED RELEASE / ORAL | 7 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | POWDER, FOR SUSPENSION / ORAL | 1.3 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eec993dc-e8a8-49dd-e053-2a95a90a0dc5 | 3a2c0e7d-a9af-4d83-8339-280df9aa70f9 | 2022-12-01 | Warnings | 3a2c0e7d-a9af-4d83-8339-280df9aa70f9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.